tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
US Market
ALLO
Allogene Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Allogene Therapeutics (ALLO) Stock News & Sentiment

Compare
1,463 Followers
Allogene Therapeutics Holds Annual Stockholder Meeting
Premium
Company Announcements
Allogene Therapeutics Holds Annual Stockholder Meeting
30d ago
8K
ALLO
Promising Clinical Results and Strategic Initiatives Drive Buy Rating for Allogene Therapeutics
Premium
Ratings
Promising Clinical Results and Strategic Initiatives Drive Buy Rating for Allogene Therapeutics
2M ago
ALLO
Allogene Therapeutics’ Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Allogene Therapeutics’ Earnings Call: Progress Amid Challenges
2M ago
ALLO
Allogene Therapeutics: Strategic Cash Management and ALPHA3 Potential Drive Buy Rating Amid Clinical Delays
Premium
Ratings
Allogene Therapeutics: Strategic Cash Management and ALPHA3 Potential Drive Buy Rating Amid Clinical Delays
2M ago
ALLO
Buy Rating Affirmed for Allogene Therapeutics Amid Strategic Developments and Financial Strength
Premium
Ratings
Buy Rating Affirmed for Allogene Therapeutics Amid Strategic Developments and Financial Strength
2M ago
ALLO
Positive Outlook on Allogene Therapeutics Amid ALPHA3 Trial Delays and Market Expansion Potential
Premium
Ratings
Positive Outlook on Allogene Therapeutics Amid ALPHA3 Trial Delays and Market Expansion Potential
2M ago
ALLO
Allogene Therapeutics Advances Clinical Trials and Extends Cash Runway
Premium
Company Announcements
Allogene Therapeutics Advances Clinical Trials and Extends Cash Runway
2M ago
ALLO
More ALLO News >

ALLO News on the Web

Betting Big on Cancer: 3 Oncology Stocks Set to Surge in 2025
Zacks
Bullish
Why Allogene Therapeutics, Inc.’s (ALLO) Stock Is Up 5.98%
AAII
Neutral
Why Allogene Therapeutics, Inc.’s (ALLO) Stock Is Up 5.69%
AAII
Neutral
Why Allogene Therapeutics, Inc.’s (ALLO) Stock Is Up 7.20%
AAII
Neutral
Why Allogene Therapeutics, Inc.’s (ALLO) Stock Is Up 7.93%
AAII
Neutral
Bernstein Reaffirms Their Hold Rating on Allogene Therapeutics (ALLO)
TipRanks News
Neutral
Why Is Allogene Therapeutics (ALLO) Up 52.2% Since Last Earnings Report?
Zacks
Neutral
Why Allogene Therapeutics, Inc.’s (ALLO) Stock Is Up 5.81%
AAII
Neutral

News Score - Last 7 Days

Neutral
ALLO
Sector Average
Media Buzz
This Week3 articles
Weekly Average1.25 articles
News Sentiment
This Week99%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ALLO’s Media Buzz Sentiment?
3 articles about ALLO were published this week. In an average week, 1.25 articles are published.
    What is ALLO’s weekly average amount of articles?
    In an average week, 1.25 articles about ALLO are published.
      What is ALLO’s News Sentiment?
      99% of articles about ALLO were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        IXIIXICO plc
        GMABGenmab
        JNJJohnson & Johnson
        ABTAbbott Laboratories
        SRPTSarepta Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing